Diversify Advisory Services LLC Has $2.13 Million Stock Position in Zoetis Inc. (NYSE:ZTS)

Diversify Advisory Services LLC trimmed its position in shares of Zoetis Inc. (NYSE:ZTS) by 16.6% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 13,047 shares of the company’s stock after selling 2,593 shares during the period. Diversify Advisory Services LLC’s holdings in Zoetis were worth $2,131,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Diversify Wealth Management LLC raised its stake in Zoetis by 72.8% in the fourth quarter. Diversify Wealth Management LLC now owns 25,224 shares of the company’s stock valued at $4,120,000 after buying an additional 10,630 shares during the period. LVW Advisors LLC increased its holdings in shares of Zoetis by 59.4% during the 4th quarter. LVW Advisors LLC now owns 2,343 shares of the company’s stock worth $382,000 after acquiring an additional 873 shares during the last quarter. Ellsworth Advisors LLC bought a new stake in Zoetis in the 4th quarter valued at $1,501,000. Grove Bank & Trust lifted its holdings in Zoetis by 36.6% during the 4th quarter. Grove Bank & Trust now owns 16,065 shares of the company’s stock valued at $2,617,000 after purchasing an additional 4,302 shares during the last quarter. Finally, Renaissance Investment Group LLC boosted its position in Zoetis by 1.3% during the fourth quarter. Renaissance Investment Group LLC now owns 52,282 shares of the company’s stock worth $8,518,000 after purchasing an additional 690 shares during the period. 92.80% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

ZTS has been the topic of several research analyst reports. Leerink Partnrs raised shares of Zoetis to a “strong-buy” rating in a research report on Monday, December 2nd. Stifel Nicolaus cut their price objective on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. UBS Group started coverage on Zoetis in a research report on Monday, December 9th. They issued a “neutral” rating and a $196.00 target price on the stock. JPMorgan Chase & Co. lifted their price target on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Finally, Leerink Partners began coverage on Zoetis in a report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price objective on the stock. One investment analyst has rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, Zoetis has a consensus rating of “Buy” and a consensus target price of $211.89.

Zoetis Stock Down 2.0 %

Shares of NYSE ZTS opened at $166.01 on Monday. The stock has a market capitalization of $74.90 billion, a P/E ratio of 31.20, a PEG ratio of 2.51 and a beta of 0.89. The stock’s fifty day moving average is $170.93 and its 200 day moving average is $179.98. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $200.53. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69.

Zoetis (NYSE:ZTS) last released its earnings results on Monday, November 4th. The company reported $1.58 EPS for the quarter, beating the consensus estimate of $1.46 by $0.12. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The firm had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.29 billion. During the same period last year, the firm earned $1.36 EPS. The business’s quarterly revenue was up 11.6% compared to the same quarter last year. Sell-side analysts forecast that Zoetis Inc. will post 5.91 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 4th. Shareholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This is a boost from Zoetis’s previous quarterly dividend of $0.43. This represents a $2.00 annualized dividend and a yield of 1.20%. Zoetis’s dividend payout ratio is presently 32.52%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.